TY - JOUR T1 - COVID-SGIS: A smart tool for dynamic monitoring and temporal forecasting of Covid-19 JF - medRxiv DO - 10.1101/2020.05.30.20117945 SP - 2020.05.30.20117945 AU - Clarisse Lins de Lima AU - Cecilia Cordeiro da Silva AU - Ana Clara Gomes da Silva AU - Eduardo Luiz Silva AU - Gabriel Souza Marques AU - Lucas Job Brito de Araújo AU - Luiz Antônio Albuquerque Júnior AU - Samuel Barbosa Jatobá de Souza AU - Maíra Araújo de Santana AU - Juliana Carneiro Gomes AU - Valter Augusto de Freitas Barbosa AU - Anwar Musah AU - Patty Kostkova AU - Wellington Pinheiro dos Santos AU - Abel Guilhermino da Silva Filho Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/03/2020.05.30.20117945.abstract N2 - Objective The new kind of coronavirus SARS-Cov2 spread to countries in all continents in the World. The coronavirus disease 2019 (Covid-19) causes fever, cough, sore throat, and in severe cases shortness of breath and death. To evaluate strategies, it is necessary to forecast the number of cases and deaths, in order to aid the stakeholders in the process of making decisions against the disease. We propose a system for real-time forecast of the cumulative cases of Covid-19 in Brazil.Study Design Monitoring of all Brazilian cities using oficial information from the National Notification System, from March to May 2020, concentrated on Brazil.io databases. Training and evaluation of ARIMA and other machine learning algorithms for temporal forecasting using correlation indexes (Pearson’s, Spearman’s, and Kendall’s) and RMSE(%). Validation from the relative errors of the following six days.Methods Our developed software, COVID-SGIS, captures information from the 26 states and the Distrito Federal at the Brazil.io database. From these data, ARIMA models are created for the accumulation of confirmed cases and death cases by Covid-19. Finally, six-day forecasts graphs are available for Brazil and for each of its federative units, separately, with a 95% CI. In addition to these predictions, the worst and best scenarios are also presented.Results ARIMA models were generated for Brazil and its 27 federative units. The states of Bahia, Maranhão, Piauí, Rio Grande do Norte and Amapá, Rondônia every day of the predictions were in the projection interval. The same happened to the states of Espírito Santo, Minas Gerais, Paraná and Santa Catarina. In Brazil, the percentage error between the predicted values and the actual values varied between 2.56% and 6.50%. For the days when the forecasts outside the prediction interval, the percentage errors in relation to the worst case scenario were below 5%. The states of Bahia, Maranhão, Piauí, Rio Grande do Norte, Amapá, and Rondônia every day of the predictions were in the projection interval. The same happened to the states of Espírito Santo, Minas Gerais, Paraná and Santa Catarina.Conclusion The proposed method for dynamic forecasting may be used to guide social policies and plan direct interventions in a robust, flexible and fast way. Since it is based on information from multiple databases, it can be adapted to the different realities, becoming an important tool to guide the course of politics and action against Covid-19 pandemic worldwide.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.cin.ufpe.br/~covidsgis https://github.com/Biomedical-Computing-UFPE/Covid-SGIS Funding StatementThis study was funded by the Federal University of Pernambuco and the Brazilian research agencies FACEPE, CAPES and CNPq.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe software code (back-end) is available at GitHub. The complete software can be used online. ER -